Tenecteplase for Stroke at 4.5 to 24 Hours

N Engl J Med. 2024 May 9;390(18):1729. doi: 10.1056/NEJMc2403602.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clinical Trials as Topic*
  • Fibrinolytic Agents* / adverse effects
  • Fibrinolytic Agents* / therapeutic use
  • Humans
  • Sample Size*
  • Stroke* / drug therapy
  • Tenecteplase* / therapeutic use
  • Time-to-Treatment